BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17689641)

  • 1. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.
    Staff AC; Braekke K; Johnsen GM; Karumanchi SA; Harsem NK
    Am J Obstet Gynecol; 2007 Aug; 197(2):176.e1-6. PubMed ID: 17689641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
    Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
    Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Ramírez-Valenzuela KL; Chinolla-Arellano ZL; Isordia-Salas I
    Hypertension; 2013 May; 61(5):1118-25. PubMed ID: 23460287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction.
    Wang CN; Chang SD; Peng HH; Lee YS; Chang YL; Cheng PJ; Chao AS; Wang TH; Wang HS
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1431-41. PubMed ID: 20080845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.
    Staff AC; Harsem NK; Braekke K; Hyer M; Hoover RN; Troisi R
    Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):29-33. PubMed ID: 19135290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia.
    Sandrim VC; Palei AC; Metzger IF; Gomes VA; Cavalli RC; Tanus-Santos JE
    Hypertension; 2008 Aug; 52(2):402-7. PubMed ID: 18574068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia.
    Tobinaga CM; Torloni MR; Gueuvoghlanian-Silva BY; Pendeloski KP; Akita PA; Sass N; Daher S
    Acta Obstet Gynecol Scand; 2014 May; 93(5):469-76. PubMed ID: 24580069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic biomarkers in pregnancy: defining maternal and fetal health.
    Rasmussen LG; Lykke JA; Staff AC
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):820-32. PubMed ID: 25753566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.